Effects of Pranlukast, a Leukotriene Receptor Antagonist, on Airway Inflammation in Mild Asthmatics

By Yamauchi Kohei   Tanifuji Yukio   Pan Li-Hua   Yoshida Takumi   Sakurai Shigeru   Goto Shin-ichi   Kuroda Shin   Kobayashi Hitoshi   Inoue Hiroshi  

Journal of Asthma, Vol. 38, Iss. 1, 2001-02 ,pp. : 51-57

Informa Healthcare

Access to resources Recommend Favorite

Functional expression of cysteinyl leukotriene receptors on human platelets

By Hasegawa Shunji   Ichiyama Takashi   Hashimoto Kunio   Suzuki Yasuo   Hirano Reiji   Fukano Reiji   Furukawa Susumu  

Platelets, Vol. 21, Iss. 4, 2010-08 ,pp. : 253-259

Informa Healthcare

Access to resources Recommend Favorite

Antitussive Effect of the Leukotriene Receptor Antagonist Zafirlukast in Subjects with Cough-Variant Asthma *

By Dicpinigaitis Peter V.   Dobkin Jay B.   Reichel Joseph  

Journal of Asthma, Vol. 39, Iss. 4, 2002-06 ,pp. : 291-297

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Chronic Cough in Children with Montelukast, a Leukotriene Receptor Antagonist

By Kopřiva František   Sobolová Lucie   Szotkowská Jarmila   Zápalka Martin  

Journal of Asthma, Vol. 41, Iss. 7, 2004-01 ,pp. : 715-720

Informa Healthcare

Access to resources Recommend Favorite

Serum interleukin-5 levels correlate with disease activity of Churg–Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid

By Taki H   Shinoda K   Hounoki H   Ogawa R   Ishizawa S   Sugiyama E   Tobe K  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 4, 2010-08 ,pp. : 341-343

Informa Healthcare

Access to resources Recommend Favorite